UNH
50
-5
CI
38
-14
THC
62
2
CSX
55
-2
JNJ
42
-2
STT
60
7
GS
52
-7
AA
43
2
NWL
54
-2
HBI
50
-2
MRK
25
2
BEN
33
-5
DAL
77
-3
COF
57
-2
CINF
37
6
LEN
52
4
EMN
48
-2
MAS
58
2
KR
38
-2
RF
53
-3
UNH
50
-5
CI
38
-14
THC
62
2
CSX
55
-2
JNJ
42
-2
STT
60
7
GS
52
-7
AA
43
2
NWL
54
-2
HBI
50
-2
MRK
25
2
BEN
33
-5
DAL
77
-3
COF
57
-2
CINF
37
6
LEN
52
4
EMN
48
-2
MAS
58
2
KR
38
-2
RF
53
-3
Financhill
Back

Arbutus Biopharma 10K Form

Buy
51

ABUS
Arbutus Biopharma

Last Price:
3.87
Seasonality Move:
20.32%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-07 10Q ABUS/Arbutus Biopharma Quarterly
2023-08-03 10Q ABUS/Arbutus Biopharma Quarterly
2023-05-04 10Q ABUS/Arbutus Biopharma Quarterly
2022-11-09 10Q ABUS/Arbutus Biopharma Quarterly
2022-08-04 10Q ABUS/Arbutus Biopharma Quarterly
2022-05-05 10Q ABUS/Arbutus Biopharma Quarterly

Receive ABUS News And Ratings

See the #1 stock for the next 7 days that we like better than ABUS

ABUS Financial Statistics

Sales & Book Value

Annual Sales: $18.14M
Cash Flow: $-14.51M
Price / Cash Flow: 0
Annual Sales: $0.65
Price / Book: 5.95

Profitability

EPS (TTM): -0.45000
Net Income (TTM): $-77.09M
Gross Margin: $-40.57M
Return on Equity: -64.55%
Return on Assets: -48.78%

Arbutus Biopharma Earnings Forecast

Key Arbutus Biopharma Financial Ratios

  • The Gross Profit Margin over the past 12 years for ABUS is -586.78%.
  • The Selling, General & Administrative Expenses for ABUS have been equal to 123.89% of Gross Profit Margin.
  • The Research & Development expenses have been 406.26% of Revenue.
  • The Interest Expense is -0.63% of Operating Income.
  • The Net Earning history of ABUS is -401.57% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 16 years.

Arbutus Biopharma Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ABUS
CUSIP: 03879J
Website: arbutusbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 6.56
Quick Ratio: 6.36

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ABUS Technical Analysis vs Fundamental Analysis

Buy
51
Arbutus Biopharma (ABUS) is a Buy

Is Arbutus Biopharma a Buy or a Sell?

  • Arbutus Biopharma stock is rated a Buy
    The current Arbutus Biopharma [ABUS] share price is $3.86. The Score for ABUS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.